سعر ميوكلير 4مجم/5مل شراب 120مل 2022

Muclear bromhexine 4 mg/5 ml syrup, 120 ml bottle (Rameda); mucolytic.

• Mucolytic in the management of viscid mucoid secretions associated with bronchitis, bronchiectasis and sinusitis.Population: Adults and children from 2 yearsHealth Products Regulatory Authority (HPRA)

• Uncommon: upper abdominal pain, nausea, vomiting, diarrhoea. Rare: hypersensitivity reactions, rash, urticaria. Not known: anaphylactic reactions including shock, bronchospasm, pruritus, angioedema, severe cutaneous adverse reactions.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Hypersensitivity to bromhexine or to any excipient.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Severe skin reactions (erythema multiforme, SJS/TEN, AGEP) have been reported with bromhexine; stop immediately and seek medical advice if a progressive rash, blisters or mucosal lesions appear.International label, same formulation · Health Products Regulatory Authority (HPRA)
• Use with caution in patients with a history of, or existing, peptic ulceration.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Antibiotics (ampicillin, amoxicillin, oxytetracycline, erythromycin)No clinically relevant unfavourable interactions with these antibiotics have been reported.Health Products Regulatory Authority (HPRA)

• Limited data in pregnant women; pre-clinical studies show no harmful reproductive effects; as a precaution it is preferable to avoid use during pregnancy.International label, same formulation · Health Products Regulatory Authority (HPRA)
• Bromhexine is excreted in milk in pre-clinical studies and a risk to the breastfed infant cannot be excluded; should not be used during breastfeeding.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Bromhexine: Increases the serous proportion of bronchial secretion, reduces mucus viscosity and activates ciliated epithelium.